← Leaderboards
Stephen Ross
New York University School Of Medicine
$3,828,592
Attributed
$7,408,835
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.1M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,408,835 · 4
By mechanism
R01$3,542,711 · 2
UG3$3,399,999 · 1
R21$466,125 · 1
Top collaborators
- Stacy M Fischer5 shared
- Jennifer M Mitchell1 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Daniel C. Javitt$42,318,725
- Malcolm S. Reid$1,417,867
Others in their field
Top investigators on “Psychologic”
- Chanza Baytop · Westat, Inc.$271,217,917
- David R. Weir · University Of Michigan At Ann Arbor$146,253,667
- David M Nathan · Massachusetts Institute Of Technology$128,782,092
- John M Lachin · George Washington University$118,672,444
- Lloyd D Johnston · University Of Michigan At Ann Arbor$106,693,063
- Jacqueline Moline · Icahn School Of Medicine At Mount Sinai$75,762,106
Research focus
PsychologicPharmaceutical PreparationsAffectResponseInnovationMental DepressionPlacebosDoseRandomizedQuality Of LifeSafetyParticipantAnxietyPainAcutePublic HealthDesignBehavior TherapyOpioidDouble-Blind MethodMortalityAdvanced Malignant NeoplasmCancer TherapyOpiate Addiction
Grant awards (10)
Psychedelics for Older Adults with Chronic Pain$3,399,999
UG3 · FY2025 · AG
Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress$662,352
R01 · FY2025 · CA · contact PI
Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress$631,533
R01 · FY2024 · CA · contact PI
Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress$651,625
R01 · FY2023 · CA · contact PI
Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress$681,645
R01 · FY2022 · CA · contact PI
Effects of cannabidiol in chronic non-cancer pain on chronic opioid therapy$211,875
R21 · FY2020 · DA · contact PI
Effects of cannabidiol in chronic non-cancer pain on chronic opioid therapy$254,250
R21 · FY2019 · DA · contact PI
Clinical Laboratory Evaluations of Aprepitant for the Treatment of Opioid Depende$180,384
R01 · FY2013 · DA · contact PI
Clinical laboratory evaluations of aprepitant for the treatment of opioid depende$365,739
R01 · FY2012 · DA · contact PI
Clinical laboratory evaluations of aprepitant for the treatment of opioid depende$369,433
R01 · FY2010 · DA · contact PI